Press Releases

May 14, 2012

Results from Two Studies Demonstrate the Clinical Utility of CardioDx Gene Expression Test in Patients with Suspected Obstructive Coronary Artery Disease

May 7, 2012

CardioDx to Present Results from Two Studies Evaluating the Clinical Utility of a Gene Expression Test for Obstructive Coronary Artery Disease

April 30, 2012

CardioDx Honored as 2012 Gold Edison Award Winner

April 2, 2012

CardioDx to Present at the 11th Annual Needham Healthcare Conference

March 19, 2012

CardioDx Announces Presentations at the American College of Cardiology 2012 Scientific Sessions

November 15, 2011

CardioDx Blood-Based Gene Expression Test Demonstrates Superior Performance to Myocardial Perfusion Imaging to Rule Out Obstructive Coronary Artery Disease

November 7, 2011

CardioDx Announces Participation at Upcoming Investor Conferences

November 3, 2011

CardioDx Announces Podium Presentations at American Heart Association Scientific Sessions 2011

September 19, 2011

CardioDx Appoints Andrew Guggenhime as Chief Financial Officer and Mark Monane, M.D., as Chief Medical Officer

May 11, 2011

CardioDx Completes $60 Million in Equity Financing

April 5, 2011

New Multi-center Trial Results Demonstrate Ability of Corus CAD to Identify Obstructive Coronary Artery Disease and Add Independent Information to Coronary Calcium Scoring by CT Angiography